AI-generated Β· cited to primary sources Β· not investment advice
The development of the high-wall seamless pipe plant is advancing on schedule for a January 2026 commencement. (2 in progress across 2 tracked commitments)
βSimultaneously, the development of our high-wall seamless pipe plant is advancing on schedule. We remain on track to commence commercial production by January 2026.β
Anticipated revenue of INR 40-50 crores from the ExxonMobil USA rate contract in the current financial year. β target: 40-50
βSo this recent one is for like 18 months, they have signed the rate contract, and we are expecting around INR40 crores, INR50 crores business in this financial year from them.β
The company expects to execute piping segment orders worth INR 1,000 to 1,100 crores in the current financial year. β target: 1000-1100 (+4 more commitments)
βAnd the present order book, which we have to execute in this financial year to cover almost in piping, it will be around INR1,100 crores or so, something -- anything between INR1,000 crores to INR1,100 crores will be there in the piping segment.β
See the full cited Management analysis of DEE Development
The company is deepening its relationships with global energy giants, specifically signing a new 18-month rate contract with ExxonMobil USA. This reinforces the moat by integrating DEE into the long-term project pipelines of major international OEMs. (1 expanding)
βSo we got the rate contract from ExxonMobil USA... this recent one is for like 18 months... we are expecting around INR40 crores, INR50 crores business in this financial year from them.β
See the full cited Business Model analysis of DEE Development
The demand outlook has stabilized and improved with the signing of a major rate contract with ExxonMobil USA (expected INR 40-50 Cr this year) and a $50 million order from Dow Chemical, of which 75-80% will be executed in FY26. (1 easing)
βwe got the rate contract from ExxonMobil USA... we are expecting around INR40 crores, INR50 crores business in this financial year from them.β
See the full cited Risk analysis of DEE Development
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.